Search Results - "Abdo, Alaa M"

Shortened 8 Weeks Course of Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients, With Chronic Hepatitis C Infection by El‐Shabrawi, Mortada H., Abdo, Alaa M., El‐Khayat, Hisham R., Yakoot, Mostafa

“…ABSTRACT Recently, sofosbuvir and the fixed‐dose combination of sofosbuvir/ledipasvir were approved for the treatment of chronic hepatitis C virus infection in…”
Get full text

Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection by Yakoot, Mostafa, El‐Shabrawi, Mortada H., AbdElgawad, Manal M., Mahfouz, Aml A., Helmy, Sherine, Abdo, Alaa M., El‐Khayat, Hisham R.

“…ABSTRACT Objectives: Dual sofosbuvir/daclatasvir (SOF/DCV) therapy is currently recommended by the European Association for Study of Liver (EASL) as an option…”
Get full text

Effects of Dual Sofosbuvir/Daclatasvir Therapy on Weight and Linear Growth in Adolescent Patients with Chronic Hepatitis C Virus Infection by Yakoot, Mostafa, El-Shabrawi, Mortada H, AbdElgawad, Manal M, Mahfouz, Aml A, Khalil, Ahmed F, Kamal, Naglaa M, Helmy, Sherine, Abdo, Alaa M, Kamal, Enas M, El-Khayat, Hisham R

“…Negative effects on growth indices had been reported in children treated with interferon for chronic viral hepatitis. Forty chronic hepatitis C virus-infected…”
Get full text

Response Tailored Protocol Versus the Fixed 12 Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial by Yakoot, Mostafa, Abdo, Alaa M., Abdel-Rehim, Siham, Helmy, Sherine

“…• It would be prudent to consider vRVR to therapy at week 2 before shortening HCV treatment duration with SOF/DCV to 8 weeks. • This will consider the…”
Get full text

Response Tailored Protocol Versus the Fixed 12Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial by Yakoot, Mostafa, Abdo, Alaa M., Abdel-Rehim, Siham, Helmy, Sherine

“…The most recent European Association for the Study of the Liver (EASL) 2016 Guidelines on treatment of hepatitis C (HCV), allowed for shortening the course of…”
Get full text

Very rapid virologic response and early HCV response kinetics, as quick measures to compare efficacy and guide a personalized response-guided therapy by Yakoot, Mostafa, Abdo, Alaa M, Yousry, Ahmed, Helmy, Sherine

“…This is the second and final report for our study designed to compare two generic sofosbuvir products for the degree and speed of virologic response to a dual…”
Get full text

The very-rapid and the ultra-rapid virologic response to two treatment options in patients with chronic hepatitis C: an interim report of a prospective randomized comparative effectiveness study by Yakoot, Mostafa, Abdo, Alaa M, Yousry, Ahmed, Helmy, Sherine

“…We aimed in this interim report to compare two registered generic sofosbuvir products for the degree and speed of virologic response to a dual antiviral…”
Get full text